✨ New Arrivals Just Dropped!Explore
Hyalgan Sodium Hyaluronate 20 mg / 2 mL Injection 2 mL
- Hyalgan is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy, and to simple analgesics
Product Specs
| Item Number | 1032048 |
|---|---|
| Catalog Number | 89122072420 |
| UOM | EA |
| Level 1 Family Description | Rx |
| Level 2 Category Description | Rx-Specialty Rx |
| Level 3 Group Description | Orange Specialty Rx |
| Level 4 Sub-Category Description | Orange - Orthopedic |
| Application | Osteoarthritis Agent |
| Brand | Hyalgan |
| Buy American Act (BAA) Compliant | No |
| Container Type | Prefilled Syringe |
| Country of Origin | Italy |
| Dosage Form | Injection |
| Generic Drug Code | 32121 |
| Generic Drug Name | Sodium Hyaluronate |
| Manufacturer | Fidia Pharma USA Inc |
| Manufacturer # | 89122072420 |
| McKesson # | 1032048 |
| NDC Number | 89122072420 |
| Strength | 20 mg / 2 mL |
| Trade Agreement Act (TAA) Compliant | Yes |
| Type | Intra-articular |
| UNSPSC Code | 51202002 |
| Volume | 2 mL |
- Hyalgan is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy, and to simple analgesics
Product Specs
| Item Number | 1032048 |
|---|---|
| Catalog Number | 89122072420 |
| UOM | EA |
| Level 1 Family Description | Rx |
| Level 2 Category Description | Rx-Specialty Rx |
| Level 3 Group Description | Orange Specialty Rx |
| Level 4 Sub-Category Description | Orange - Orthopedic |
| Application | Osteoarthritis Agent |
| Brand | Hyalgan |
| Buy American Act (BAA) Compliant | No |
| Container Type | Prefilled Syringe |
| Country of Origin | Italy |
| Dosage Form | Injection |
| Generic Drug Code | 32121 |
| Generic Drug Name | Sodium Hyaluronate |
| Manufacturer | Fidia Pharma USA Inc |
| Manufacturer # | 89122072420 |
| McKesson # | 1032048 |
| NDC Number | 89122072420 |
| Strength | 20 mg / 2 mL |
| Trade Agreement Act (TAA) Compliant | Yes |
| Type | Intra-articular |
| UNSPSC Code | 51202002 |
| Volume | 2 mL |
$77.76
Original: $222.17
-65%Hyalgan Sodium Hyaluronate 20 mg / 2 mL Injection 2 mL—
$222.17
$77.76Description
- Hyalgan is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy, and to simple analgesics
Product Specs
| Item Number | 1032048 |
|---|---|
| Catalog Number | 89122072420 |
| UOM | EA |
| Level 1 Family Description | Rx |
| Level 2 Category Description | Rx-Specialty Rx |
| Level 3 Group Description | Orange Specialty Rx |
| Level 4 Sub-Category Description | Orange - Orthopedic |
| Application | Osteoarthritis Agent |
| Brand | Hyalgan |
| Buy American Act (BAA) Compliant | No |
| Container Type | Prefilled Syringe |
| Country of Origin | Italy |
| Dosage Form | Injection |
| Generic Drug Code | 32121 |
| Generic Drug Name | Sodium Hyaluronate |
| Manufacturer | Fidia Pharma USA Inc |
| Manufacturer # | 89122072420 |
| McKesson # | 1032048 |
| NDC Number | 89122072420 |
| Strength | 20 mg / 2 mL |
| Trade Agreement Act (TAA) Compliant | Yes |
| Type | Intra-articular |
| UNSPSC Code | 51202002 |
| Volume | 2 mL |
